Author: eczemarelief
Air pollution is a major contributor to lung disease, but a study shows that it can damage most other organ systems of the body. Photo : iStock New Delhi:As a major environmental risk factor, air pollution has evolved as a serious problem in recent decades with high toxicological impact on human health ranging from lungs […]
Ruxolitinib cream 1.5% (Opezlura) was approved by the US Food and Drug Administration (FDA) this July for the treatment of nonsegmental vitiligo—a novel, breakthrough indication for a topical JAK inhibitor in a space with few options. Incyte’s agent may be next considered for a chronic skin disease with a more robust armamentarium: atopic dermatitis, which […]
Tapering off dosages of secukinumab might be equally efficacious as previous regimens for patients with plaque psoriasis. A team, led by Xi-Bei Chen, Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, assessed the feasibility, efficacy, and safety of gradually increasing the secukinumab dosing interval in patients with plaque psoriasis. The Drug: Secukinumab Secukinumab […]
A team of voters have assessed several tools for measuring and assessing itch intensity for patients with atopic eczema. A team, led by Yael A. Leshem, MD, MCR, Division of Dermatology, Rabin Medical Center, recommended instruments to measure eczema control and itch intensity in patients with atopic eczema in clinical practice. “Measuring outcomes in clinical […]